Analysis
| Earnings estimate |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of analysts | 12 | 12 | 14 | 13 |
| Average estimate | 8.77 | 9.76 | 37.43 | 41.93 |
| Low estimate | 8.17 | 9.19 | 35.76 | 39.38 |
| High estimate | 9.05 | 9.95 | 37.81 | 42.95 |
| Last year EPS | 7.07 | 8.03 | 33.05 | 37.43 |
| Revenue estimate |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of Analysts | 11 | 11 | 14 | 13 |
| Avg. estimate | 103.55B | 105.19B | 407.56B | 437.12B |
| Low estimate | 100.62B | 103.11B | 403.18B | 423.25B |
| High estimate | 106.27B | 107.26B | 415B | 445.38B |
| Last year sales | 93.65B | 95.29B | 359.05B | 407.56B |
| Sales growth | 0.11 | 0.10 | 0.14 | 0.07 |
| EPS trend |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Current estimate | 8.77 | 9.76 | 37.43 | 41.93 |
| 7 days ago | 8.82 | 9.75 | 37.40 | 41.95 |
| 30 days ago | 8.78 | 9.73 | 37.35 | 41.95 |
| 60 days ago | 8.73 | 9.68 | 37.31 | 41.89 |
| 90 days ago | 8.73 | 9.59 | 37.08 | 41.58 |
| EPS revisions |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Up last 7 days | 2 | 2 | 2 | 1 |
| Up last 30 days | 3 | 5 | 6 | 3 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 2 | 0 | 0 | 1 |
| Growth estimates | |
|---|---|
| Current qtr (Aug 2025) | 0.241% |
| Next qtr. (Nov 2025) | 0.215% |
| Current year (2025) | 0.133% |
| Next 5 years (per annum) | 0.163% |
| Past 5 years (per annum) | 0.216% |